Detailed information for compound 28838
Basic information
Technical information
- TDR Targets ID: 28838
- Name: (2S)-2-[[5-(1-benzofuran-2-yl)thiophen-2-yl]m ethyl-(2,4-dichlorobenzoyl)amino]-3-phenylpro panoic acid
- MW: 550.452 | Formula: C29H21Cl2NO4S
-
H donors: 1
H acceptors: 3
LogP: 7.53
Rotable bonds: 9
Rule of 5 violations (Lipinski): 2 - SMILES: Clc1ccc(c(c1)Cl)C(=O)N([C@H](C(=O)O)Cc1ccccc1)Cc1ccc(s1)c1cc2c(o1)cccc2
- InChi: 1S/C29H21Cl2NO4S/c30-20-10-12-22(23(31)16-20)28(33)32(24(29(34)35)14-18-6-2-1-3-7-18)17-21-11-13-27(37-21)26-15-19-8-4-5-9-25(19)36-26/h1-13,15-16,24H,14,17H2,(H,34,35)/t24-/m0/s1
- InChiKey: YBULOUKTPCHXAL-DEOSSOPVSA-N
Network
Hover on a compound node to display the structore
Synonyms
- (2S)-2-[[5-(benzofuran-2-yl)-2-thienyl]methyl-(2,4-dichlorobenzoyl)amino]-3-phenyl-propanoic acid
- (2S)-2-[[5-(2-benzofuranyl)-2-thienyl]methyl-[(2,4-dichlorophenyl)-oxomethyl]amino]-3-phenylpropanoic acid
- (2S)-2-[[5-(1-benzofuran-2-yl)thiophen-2-yl]methyl-(2,4-dichlorophenyl)carbonyl-amino]-3-phenyl-propanoic acid
- (2S)-2-[[5-(benzofuran-2-yl)-2-thienyl]methyl-(2,4-dichlorobenzoyl)amino]-3-phenyl-propionic acid
- (2S)-2-[(5-Benzofuran-2-yl-thiophen-2-ylmethyl)-(2,4-dichlorobenzoyl)-amino]-3-phenyl-propionic acid
- AIDS-167796
- AIDS167796
- L-Phenylalanine, N-[[5-(2-benzofuranyl)-2-thienyl]methyl]-N-(2,4-dichlorobenzoyl)-
Targets
Known targets for this compound
| Species | Target name | Source | Bibliographic reference |
|---|---|---|---|
| Hepatitis C virus | Hepatitis C virus NS5B RNA-dependent RNA polymerase | Starlite/ChEMBL | References |
| Hepatitis C virus | Hepatitis C virus NS3 protease/helicase | Starlite/ChEMBL | References |
Predicted pathogen targets for this compound
By orthology
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Entamoeba histolytica | Ras family GTPase | 0.0245 | 0.5 | 0.5 |
| Echinococcus granulosus | ras gtpase | 0.0245 | 0.5 | 0.5 |
| Trichomonas vaginalis | rap1 and, putative | 0.0245 | 0.5 | 0.5 |
| Loa Loa (eye worm) | hypothetical protein | 0.0245 | 0.5 | 0.5 |
| Echinococcus multilocularis | ras gtpase | 0.0245 | 0.5 | 0.5 |
| Trichomonas vaginalis | ral, putative | 0.0245 | 0.5 | 0.5 |
| Trichomonas vaginalis | ras-dva small GTPase, putative | 0.0245 | 0.5 | 0.5 |
| Loa Loa (eye worm) | Ras protein let-60 | 0.0245 | 0.5 | 0.5 |
| Trichomonas vaginalis | rheb, putative | 0.0245 | 0.5 | 0.5 |
| Brugia malayi | Ras-related protein R-Ras2 | 0.0245 | 0.5 | 0.5 |
| Trichomonas vaginalis | dexras1, putative | 0.0245 | 0.5 | 0.5 |
| Entamoeba histolytica | Ras family GTPase | 0.0245 | 0.5 | 0.5 |
| Entamoeba histolytica | ras-1, putative | 0.0245 | 0.5 | 0.5 |
| Trichomonas vaginalis | GTP-binding protein rit, putative | 0.0245 | 0.5 | 0.5 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| IC50 (binding) | = 8.6 uM | Inhibitory activity against Hepatitis C RNA dependent RNA polymerase Nonstructural protein 5B (NS5B polymerase) expressed from baculovirus-infected Sf9 insect cells | ChEMBL. | 12672227 |
| IC50 (binding) | = 8.6 uM | Inhibitory activity against Hepatitis C RNA dependent RNA polymerase Nonstructural protein 5B (NS5B polymerase) expressed from baculovirus-infected Sf9 insect cells | ChEMBL. | 12672227 |
| Ki (binding) | = 2.2 uM | Inhibitory constant of the compound against hepatitis C virus NS3 protease | ChEMBL. | 15633995 |
| Ki (binding) | = 2.2 uM | Inhibitory constant of the compound against hepatitis C virus NS3 protease | ChEMBL. | 15633995 |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- ChEMBL: CHEMBL278785
- PubChem: 447369
Bibliographic References
2 literature references were collected for this gene.
If you have references for this compound, please enter them in a user comment (below) or Contact us.